Trials / Withdrawn
WithdrawnNCT00672672
Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Nebraska · Academic / Other
- Sex
- All
- Age
- 19 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This study will determine if autologous platelet gel (APG) on sternal incision and conduit sites will improve wound healing and decrease infection in coronary artery bypass grafting surgery patients.
Detailed description
The purpose of this study is to determine if the use of autologous platelet gel (APG) on sternal incision and conduit sites will improve wound healing and decrease the incidence of infection in patients undergoing coronary artery bypass grafting surgery
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | autologous platelet gel | Patients will receive APG to the surgical site in the operating room. The control site will receive no treatment. |
Timeline
- Start date
- 2009-01-13
- Primary completion
- 2010-01-06
- Completion
- 2010-01-06
- First posted
- 2008-05-06
- Last updated
- 2023-08-15
Source: ClinicalTrials.gov record NCT00672672. Inclusion in this directory is not an endorsement.